A study on TLR9 polymorphisms rs5743836, rs352140, rs187084, and rs352139 in OSSC patients found that all investigated variants could increase the oral cancer risk and potentiate bacterial gingival inflammation/gingival recession [25]. Here, TLR9 is linked to inflammation.